this post was submitted on 14 May 2025
54 points (98.2% liked)

World News

46548 readers
1944 users here now

A community for discussing events around the World

Rules:

Similarly, if you see posts along these lines, do not engage. Report them, block them, and live a happier life than they do. We see too many slapfights that boil down to "Mom! He's bugging me!" and "I'm not touching you!" Going forward, slapfights will result in removed comments and temp bans to cool off.

We ask that the users report any comment or post that violate the rules, to use critical thinking when reading, posting or commenting. Users that post off-topic spam, advocate violence, have multiple comments or posts removed, weaponize reports or violate the code of conduct will be banned.

All posts and comments will be reviewed on a case-by-case basis. This means that some content that violates the rules may be allowed, while other content that does not violate the rules may be removed. The moderators retain the right to remove any content and ban users.


Lemmy World Partners

News [email protected]

Politics [email protected]

World Politics [email protected]


Recommendations

For Firefox users, there is media bias / propaganda / fact check plugin.

https://addons.mozilla.org/en-US/firefox/addon/media-bias-fact-check/

founded 2 years ago
MODERATORS
 

In the U.S., drug prices are shaped by complex negotiations involving pharmacy benefit managers that act as middlemen between drugmakers and employer clients and health insurers and have been criticised for inflating costs. In Europe, countries generally have public health systems that negotiate directly with manufacturers and keep costs down.

/.../

Trump said if drugmakers do not cut prices they could be hit with tariffs.

you are viewing a single comment's thread
view the rest of the comments
[–] [email protected] 11 points 14 hours ago (1 children)

Pharmaceutical companies will demand higher prices from countries with socialized healthcare. Those higher costs will be passed on to the citizens of those countries. Those citizens will get angry(ier) at the US. US citizens will see little to no cost reduction in drug prices, but any, no matter how minor, will be touted as a victory by Team Trump. And none of them will ever recognize why countries with socialized healthcare can negotiate lower drug costs.

The end result is the US becomes even more isolated and hated by the world.

[–] [email protected] 6 points 13 hours ago* (last edited 13 hours ago)

Pharmaceutical companies will demand higher prices from countries with socialized healthcare. Those higher costs will be passed on to the citizens of those countries.

I've tried to analyze whether this can happen.

Maybe. Countries with socialized health care typically have disproportionately great bargaining power relative to their size. A pharamaceutical company may not be inclined to demand higher prices from a customer who buys great quantities.

Countries may also enter international alliances to obtain cheaper access to some product, like the EU did in case of COVID vaccines. Currently, companies have contracts they cannot back out from. Countries with single payer systems also have laws which regulate the purchase of pharamaceuticals, and those won't be changing soon.

Basically, it seems that the only thing Trump can do to immediately alter prices, is to start a trade war. Which would raise prices for US consumers and lead to unreliable access to certain drugs, putting people's lives in direct danger.

Finally, even if we suppose that one category of customers agree to pay higher prices (likely not for long, foreign competitors would quickly step in and offer alternatives) - there's no guarantee that savings obtained in such a way will be passed down to another category of customers (who have lower bargaining power) without legislation to ensure that. But legislation comes from the Congress...